Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

10.1111/bcp.13008

Saved in:

Bibliographic Details
Main Authors:	Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Hwang, Soomi, Rieder, Michael J, Bhavsar, Amit P, Smith, Anne, Sanatani, Shubhayan, Gelmon, Karen A, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C
Other Authors:	MEDICINE
Format:	Review
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy anthracycline cardiotoxicity heart-failure guidelines pharmacogenomics cancer ACUTE LYMPHOBLASTIC-LEUKEMIA ADVANCED BREAST-CANCER CONTINUOUS INTRAVENOUS-INFUSION DOXORUBICIN-INDUCED CARDIOTOXICITY LIPOSOME-ENCAPSULATED DOXORUBICIN ADRIAMYCIN-INDUCED CARDIOMYOPATHY CONGESTIVE-HEART-FAILURE NON-HODGKIN-LYMPHOMA LONG-TERM SURVIVORS B-CELL LYMPHOMA
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235077
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-235077
record_format	dspace
spelling	sg-nus-scholar.10635-2350772024-04-18T01:06:56Z Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity Aminkeng, Folefac Ross, Colin JD Rassekh, Shahrad R Hwang, Soomi Rieder, Michael J Bhavsar, Amit P Smith, Anne Sanatani, Shubhayan Gelmon, Karen A Bernstein, Daniel Hayden, Michael R Amstutz, Ursula Carleton, Bruce C MEDICINE Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy anthracycline cardiotoxicity heart-failure guidelines pharmacogenomics cancer ACUTE LYMPHOBLASTIC-LEUKEMIA ADVANCED BREAST-CANCER CONTINUOUS INTRAVENOUS-INFUSION DOXORUBICIN-INDUCED CARDIOTOXICITY LIPOSOME-ENCAPSULATED DOXORUBICIN ADRIAMYCIN-INDUCED CARDIOMYOPATHY CONGESTIVE-HEART-FAILURE NON-HODGKIN-LYMPHOMA LONG-TERM SURVIVORS B-CELL LYMPHOMA 10.1111/bcp.13008 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 82 3 683-695 2022-12-01T07:54:11Z 2022-12-01T07:54:11Z 2016-09-01 2022-11-30T18:25:52Z Review Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Hwang, Soomi, Rieder, Michael J, Bhavsar, Amit P, Smith, Anne, Sanatani, Shubhayan, Gelmon, Karen A, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C (2016-09-01). Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 82 (3) : 683-695. ScholarBank@NUS Repository. https://doi.org/10.1111/bcp.13008 0306-5251 1365-2125 https://scholarbank.nus.edu.sg/handle/10635/235077 en WILEY Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy anthracycline cardiotoxicity heart-failure guidelines pharmacogenomics cancer ACUTE LYMPHOBLASTIC-LEUKEMIA ADVANCED BREAST-CANCER CONTINUOUS INTRAVENOUS-INFUSION DOXORUBICIN-INDUCED CARDIOTOXICITY LIPOSOME-ENCAPSULATED DOXORUBICIN ADRIAMYCIN-INDUCED CARDIOMYOPATHY CONGESTIVE-HEART-FAILURE NON-HODGKIN-LYMPHOMA LONG-TERM SURVIVORS B-CELL LYMPHOMA
spellingShingle	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy anthracycline cardiotoxicity heart-failure guidelines pharmacogenomics cancer ACUTE LYMPHOBLASTIC-LEUKEMIA ADVANCED BREAST-CANCER CONTINUOUS INTRAVENOUS-INFUSION DOXORUBICIN-INDUCED CARDIOTOXICITY LIPOSOME-ENCAPSULATED DOXORUBICIN ADRIAMYCIN-INDUCED CARDIOMYOPATHY CONGESTIVE-HEART-FAILURE NON-HODGKIN-LYMPHOMA LONG-TERM SURVIVORS B-CELL LYMPHOMA Aminkeng, Folefac Ross, Colin JD Rassekh, Shahrad R Hwang, Soomi Rieder, Michael J Bhavsar, Amit P Smith, Anne Sanatani, Shubhayan Gelmon, Karen A Bernstein, Daniel Hayden, Michael R Amstutz, Ursula Carleton, Bruce C Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
description	10.1111/bcp.13008
author2	MEDICINE
author_facet	MEDICINE Aminkeng, Folefac Ross, Colin JD Rassekh, Shahrad R Hwang, Soomi Rieder, Michael J Bhavsar, Amit P Smith, Anne Sanatani, Shubhayan Gelmon, Karen A Bernstein, Daniel Hayden, Michael R Amstutz, Ursula Carleton, Bruce C
format	Review
author	Aminkeng, Folefac Ross, Colin JD Rassekh, Shahrad R Hwang, Soomi Rieder, Michael J Bhavsar, Amit P Smith, Anne Sanatani, Shubhayan Gelmon, Karen A Bernstein, Daniel Hayden, Michael R Amstutz, Ursula Carleton, Bruce C
author_sort	Aminkeng, Folefac
title	Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
title_short	Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
title_full	Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
title_fullStr	Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
title_full_unstemmed	Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
title_sort	recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
publisher	WILEY
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/235077
_version_	1800915744124305408

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

Similar Items